Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Holders of 5% or more of IMRN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Immuron Ltd, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Immuron Ltd on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Immuron Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 7, 2021 | Sabby Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Immuron Ltd shares.
No Form 144 notices for Immuron Ltd are on file.